HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anas Younes Selected Research

N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamide

6/2011Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Anas Younes Research Topics

Disease

30Hodgkin Disease (Hodgkin's Disease)
06/2012 - 01/2002
22Neoplasms (Cancer)
01/2012 - 03/2002
15Lymphoma (Lymphomas)
11/2012 - 09/2003
12Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2012 - 09/2003
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2012 - 12/2003
5Disease Progression
07/2012 - 03/2004
3Hematologic Neoplasms (Hematological Malignancy)
11/2012 - 02/2008
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2011 - 12/2003
2Necrosis
01/2007 - 08/2003
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2007 - 03/2003
1Infection
07/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2012
1Leukemia
02/2012
1Testicular Neoplasms (Testicular Cancer)
10/2011
1Hematologic Diseases (Blood Diseases)
06/2011
1Pericardial Effusion
06/2011
1Conjunctivitis
09/2009
1Hyperuricemia
06/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2007
1Colonic Neoplasms (Colon Cancer)
01/2007
1Pain (Aches)
11/2006

Drug/Important Bio-Agent (IBA)

6rituximab (Mabthera)FDA Link
07/2012 - 10/2005
5Doxorubicin (Adriamycin)FDA LinkGeneric
05/2012 - 12/2004
3fludarabineIBA
03/2012 - 02/2008
3gemcitabineFDA Link
03/2012 - 02/2008
3CytokinesIBA
10/2011 - 01/2005
3Proteins (Proteins, Gene)IBA
01/2010 - 05/2004
3NF-kappa B (NF-kB)IBA
05/2004 - 01/2002
2Adenosine Triphosphate (ATP)IBA
07/2012 - 01/2012
2Bleomycin (Blenoxane)FDA LinkGeneric
05/2012 - 11/2006
2Dacarbazine (DIC)FDA LinkGeneric
05/2012 - 11/2006
2Vinblastine (Vinblastine Sulfate)FDA Link
05/2012 - 11/2006
2Melphalan (Alkeran)FDA LinkGeneric
03/2012 - 02/2008
2Monoclonal AntibodiesIBA
11/2011 - 01/2007
2N 30IBA
10/2011 - 03/2002
2AntigensIBA
10/2011 - 01/2007
2Histone Deacetylase InhibitorsIBA
10/2011 - 12/2010
2temsirolimusFDA Link
01/2010 - 04/2008
2mTOR proteinIBA
07/2008 - 04/2008
2galiximabIBA
01/2007 - 03/2003
2Vincristine (Oncovin)FDA LinkGeneric
01/2007 - 12/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007 - 12/2004
2VaccinesIBA
01/2007 - 08/2004
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2007 - 12/2006
2Prednisone (Sone)FDA LinkGeneric
01/2007 - 12/2004
2anaplastic lymphoma kinaseIBA
12/2006 - 12/2003
2pegfilgrastim (Neulasta)FDA Link
11/2006 - 03/2006
2bortezomib (Velcade)FDA Link
02/2006 - 05/2004
2Methotrexate (Mexate)FDA LinkGeneric
10/2005 - 12/2003
1Janus Kinase 2IBA
11/2012
1Small Interfering RNA (siRNA)IBA
07/2012
1lenalidomide (CC 5013)FDA Link
07/2012
1LBH589IBA
06/2012
1ABT-737IBA
02/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2012
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2012
1CD30 AntigensIBA
10/2011
1Interleukin-12 (IL 12)IBA
10/2011
1ChemokinesIBA
10/2011
1N- (2- aminophenyl)- 4- (N- (pyridin- 3- ylmethoxycarbonyl)aminomethyl)benzamide (MS 275)IBA
10/2011
1Interleukin-13IBA
10/2011
1Chemokine CCL17IBA
10/2011
1InterferonsIBA
10/2011
1Interleukin-4 (Interleukin 4)IBA
10/2011
1Chemokine CCL5IBA
10/2011
1N- (2- aminophenyl)- 4- ((4- pyridin- 3- ylpyrimidin- 2- ylamino)methyl)benzamideIBA
06/2011
1EnzymesIBA
11/2009
1Histone Deacetylases (Histone Deacetylase)IBA
11/2009
1dacetuzumabIBA
09/2009
1Investigational DrugsIBA
05/2009
1rasburicase (Elitek)FDA Link
06/2008
1Allopurinol (Remid)FDA LinkGeneric
06/2008
1pyrimidineIBA
05/2008
1Cyclin D1IBA
04/2008
1vorinostat (suberoylanilide hydroxamic acid)FDA Link
04/2008
1GalliumIBA
06/2007
1B-Cell Activating FactorIBA
02/2007
1siplizumabIBA
01/2007
1MDX 060IBA
01/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007
1alemtuzumab (Campath)FDA Link
01/2007
1hLL2 agent (epratuzumab)IBA
01/2007
1bevacizumabFDA Link
01/2007
1Immunoconjugates (Immunoconjugate)IBA
01/2007
1AntibodiesIBA
01/2007
1CMC544 (Inotuzumab Ozogamicin)IBA
01/2007
1mapatumumabIBA
01/2007
1nucleophosminIBA
12/2006
1U 0126 (UO 126)IBA
12/2006
117-(allylamino)-17-demethoxygeldanamycin (17AAG)IBA
12/2006
1Staphylococcal Protein A (A, Protein)IBA
12/2006

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2012 - 03/2002
10Stem Cell Transplantation
07/2012 - 12/2003
3Transplants (Transplant)
03/2012 - 02/2008
3Radiotherapy
01/2003 - 03/2002
2Homologous Transplantation (Allograft)
02/2008 - 12/2003
1Immunotherapy
02/2008
1Combination Drug Therapy (Combination Chemotherapy)
05/2007
1Intradermal Injections
01/2007